Table S5. from Clinical Validity of FoundationOne Liquid CDx for Detection of <i>BRAF</i><sup>V600E</sup> in Colorectal Cancer
<p>Summary statistics of estimated log(HR) and ORR difference for the F1LCDx+/CTA+ population (𝜹𝟏) on imputed complete data.</p>
Authors
- Lincoln W. Pasquina (ORCID: https://orcid.org/0009-0009-5461-9777)
- Shibing Deng (ORCID: https://orcid.org/0000-0002-2867-263X)
- Jean-François Martini (ORCID: https://orcid.org/0000-0001-8570-1401)
- Scott Kopetz (ORCID: https://orcid.org/0000-0001-9647-3416)
- Xiaosong Zhang
- Josep M. Tabernero (ORCID: https://orcid.org/0000-0002-2495-8139)
- Fatima Kaiser
- Brian Tunquist (ORCID: https://orcid.org/0009-0001-9897-2806)
- Rona Yaeger (ORCID: https://orcid.org/0000-0002-7233-5454)
- James M. Kiely
- Ta-Chou Vincent Ng (ORCID: https://orcid.org/0000-0003-1446-5864)
- Norberto Pantoja Galicia (ORCID: https://orcid.org/0000-0001-8614-5216)
- Cui Guo (ORCID: https://orcid.org/0000-0002-3297-119X)
- Graham Ferrier
- Siliang Gong (ORCID: https://orcid.org/0009-0002-8012-9551)
Publication Details
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1158/2767-9764.30083871
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00